Back to search

Article

Bacteriostatic antibiotics promote the evolution of CRISPR-Cas immunity

2021-05-04

Abstract excerpt

Phage therapy can be used in combination with antibiotics to combat infections with bacterial pathogens 1–3 . However, bacteria can rapidly evolve phage resistance via receptor mutation, or using their CRISPR-Cas adaptive immune systems 4 , which insert short phage-derived sequences into CRISPR loci in the bacterial genome 5 to guide sequence-specific cleavage of cognate sequences 6 . Unlike CRISPR-Cas immunit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8e1f7650-8be4-5597-8923-a2a433a29d12
DOI
10.1101/2021.05.04.442568
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Bacteriostatic antibiotics promote the evolution of CRISPR-Cas immunityDOI 10.1101/2021.05.04.442568
Select a neighboring publication to make it the new centre.